Andrew Reardon - CLO & Secretary at LIGAND PHARMACEUTICALS INC

Insider Transactions and Holdings

Entity Type
Individual
Role
CLO & Secretary
Issuer Symbol
LGND on Nasdaq, LGNDZ, LGNXZ, LGNYZ, LGNZZ on OTC
All Insider Reports
All Insider Reports

Andrew Reardon - trading volume in the past year for LIGAND PHARMACEUTICALS INC

Holdings reported by Andrew Reardon for LIGAND PHARMACEUTICALS INC

Security Num Shares Value Price $ Transaction Date Ownership Underlying Class Underlying Amount
Common Stock 30,811 $4,623,498 $150.06 10 Aug 2025 Direct
Non-Qualified Stock Option (right to buy) 61,444 28 Aug 2024 Direct Common Stock
Employee Stock Option (right to buy) 28,043 04 Mar 2025 Direct Common Stock

Transactions reported by Andrew Reardon for LIGAND PHARMACEUTICALS INC

Sym Class Transaction % Value $ * Price $ Shares Shares After Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.